• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Unraveling the intricacies of neoadjuvant immune checkpoint blockade in esophageal squamous cell carcinoma: a comprehensive single-cell perspective.从单细胞综合视角解析食管鳞状细胞癌新辅助免疫检查点阻断的复杂性
J Thorac Dis. 2024 Feb 29;16(2):826-828. doi: 10.21037/jtd-23-1771. Epub 2024 Feb 20.
2
Progenitor-like exhausted SPRY1CD8 T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma.祖细胞样耗竭 SPRY1CD8+T 细胞增强了对食管鳞癌新辅助 PD-1 阻断的反应性。
Cancer Cell. 2023 Nov 13;41(11):1852-1870.e9. doi: 10.1016/j.ccell.2023.09.011. Epub 2023 Oct 12.
3
High-dimensional single-cell proteomics analysis of esophageal squamous cell carcinoma reveals dynamic alterations of the tumor immune microenvironment after neoadjuvant therapy.食管鳞状细胞癌的高维单细胞蛋白质组学分析揭示了新辅助治疗后肿瘤免疫微环境的动态变化。
J Immunother Cancer. 2023 Nov 28;11(11):e007847. doi: 10.1136/jitc-2023-007847.
4
Tumor Niche Network-Defined Subtypes Predict Immunotherapy Response of Esophageal Squamous Cell Cancer.肿瘤微环境网络定义的亚型可预测食管鳞状细胞癌的免疫治疗反应。
bioRxiv. 2023 Feb 15:2023.02.15.528539. doi: 10.1101/2023.02.15.528539.
5
Radiation-Induced Remodeling of the Tumor Microenvironment Through Tumor Cell-Intrinsic Expression of cGAS-STING in Esophageal Squamous Cell Carcinoma.通过食管鳞状细胞癌中肿瘤细胞固有表达的cGAS-STING介导的辐射诱导肿瘤微环境重塑
Int J Radiat Oncol Biol Phys. 2023 Mar 15;115(4):957-971. doi: 10.1016/j.ijrobp.2022.10.028. Epub 2022 Nov 8.
6
PES1 reduces CD8 T cell infiltration and immunotherapy sensitivity via interrupting ILF3-IL15 complex in esophageal squamous cell carcinoma.PES1 通过中断食管鳞状细胞癌中的 ILF3-IL15 复合物来减少 CD8 T 细胞浸润和免疫治疗敏感性。
J Biomed Sci. 2023 Mar 23;30(1):20. doi: 10.1186/s12929-023-00912-8.
7
Neoadjuvant chemotherapy enhances anti-tumor immune response of tumor microenvironment in human esophageal squamous cell carcinoma.新辅助化疗增强人食管鳞状细胞癌肿瘤微环境的抗肿瘤免疫反应。
iScience. 2023 Mar 21;26(4):106480. doi: 10.1016/j.isci.2023.106480. eCollection 2023 Apr 21.
8
Immunological Responses Associated With Neoadjuvant Therapy in the Tumor Microenvironment of Esophageal Squamous Cell Carcinoma.免疫反应与食管鳞癌肿瘤微环境中的新辅助治疗相关。
Anticancer Res. 2023 Oct;43(10):4691-4700. doi: 10.21873/anticanres.16665.
9
Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment.食管鳞状细胞癌中的免疫逃逸：从肿瘤微环境的角度来看
Front Oncol. 2023 Jan 9;12:1096717. doi: 10.3389/fonc.2022.1096717. eCollection 2022.
10
Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma.新辅助放化疗对食管鳞癌免疫景观的影响。
EBioMedicine. 2022 Dec;86:104371. doi: 10.1016/j.ebiom.2022.104371. Epub 2022 Nov 23.

引用本文的文献

1
Spatial proteomic profiling elucidates immune determinants of neoadjuvant chemo-immunotherapy in esophageal squamous cell carcinoma.空间蛋白质组学分析揭示了新辅助化疗免疫治疗食管鳞癌的免疫决定因素。
Oncogene. 2024 Sep;43(37):2751-2767. doi: 10.1038/s41388-024-03123-z. Epub 2024 Aug 9.

本文引用的文献

1
Progenitor-like exhausted SPRY1CD8 T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma.祖细胞样耗竭 SPRY1CD8+T 细胞增强了对食管鳞癌新辅助 PD-1 阻断的反应性。
Cancer Cell. 2023 Nov 13;41(11):1852-1870.e9. doi: 10.1016/j.ccell.2023.09.011. Epub 2023 Oct 12.
2
Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma.卡瑞利珠单抗联合化疗新辅助治疗局部晚期食管鳞癌的多中心、单臂、Ⅱ期临床研究。
J Immunother Cancer. 2022 Mar;10(3). doi: 10.1136/jitc-2021-004291.
3
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.新辅助放化疗联合手术治疗食管癌的 10 年结果：随机对照 CROSS 试验。
J Clin Oncol. 2021 Jun 20;39(18):1995-2004. doi: 10.1200/JCO.20.03614. Epub 2021 Apr 23.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
Recurrence patterns after neoadjuvant chemoradiotherapy compared with surgery alone in oesophageal squamous cell carcinoma: results from the multicenter phase III trial NEOCRTEC5010.新辅助放化疗联合手术与单纯手术治疗食管鳞癌的复发模式比较：多中心 III 期 NEOCRTEC5010 试验结果。
Eur J Cancer. 2020 Oct;138:113-121. doi: 10.1016/j.ejca.2020.08.002. Epub 2020 Aug 30.
6
Epidemiology of Esophageal Squamous Cell Carcinoma.食管鳞状细胞癌的流行病学
Gastroenterology. 2018 Jan;154(2):360-373. doi: 10.1053/j.gastro.2017.08.023. Epub 2017 Aug 18.

Unraveling the intricacies of neoadjuvant immune checkpoint blockade in esophageal squamous cell carcinoma: a comprehensive single-cell perspective.

作者信息

Zou Gengyi, Anwar Junaid, Pizzi Melissa P, Abdelhakeem Ahmed

机构信息

Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Department of Medicine, Baptist Hospitals of Southeast Texas, Beaumont, TX, USA.

出版信息

J Thorac Dis. 2024 Feb 29;16(2):826-828. doi: 10.21037/jtd-23-1771. Epub 2024 Feb 20.

DOI:10.21037/jtd-23-1771
PMID:38505072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10944718/
Abstract
摘要